KFSHRC Showcases Its Innovations and Health Solutions at the Global Health Exhibition 2024
RIYADH, Saudi Arabia, Oct. 17, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) will participate as...
RIYADH, Saudi Arabia, Oct. 17, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) will participate as...
Rapid oxygen delivery designed to help underground and confined space workers escape dangerous environments safely. Fast-activating self-rescue device for immediate...
Healthtech Investments Surpass Pre-Pandemic Levels, Stabilizing Between $3.5B and $4.5B Per Quarter in 2024 SAN FRANCISCO, Oct. 16, 2024 /PRNewswire/...
Paige to participate with PathPresenter at Pathology Visions preconference workshopMONTVILLE, NJ / ACCESSWIRE / October 16, 2024 / PathPresenter, a...
PLANO, Texas, Oct. 15, 2024 /PRNewswire/ -- For far too long, the world of healthcare workforce management has grown stagnant....
COPENHAGEN, Denmark, Oct. 15, 2024 /PRNewswire/ -- Clinical Microbiomics A/S ("CMC"), a leading innovator in multi-omics, bioinformatics and systems biology...
Partnership Will Enhance Support for Biopharmaceutical Companies in Developing Cell and Gene Therapies and mRNA-Based Treatments NASHVILLE, Tenn. and CONROE,...
New capabilities include automated fax processing and patient-facing omnichannel concierge SAN FRANCISCO, Oct. 15, 2024 /PRNewswire/ -- Today, Luma Health...
STONY BROOK, NY / ACCESSWIRE / October 15, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA"), a leader in...
MINNEAPOLIS, MN, Oct. 15, 2024 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (the “Company” or “FOXO”), provides a shareholder letter from...
HONG KONG, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE), a leading health sciences company, today announced...
-Subject 1 and Subject 2 experienced durable, clinically meaningful improvements in swallowing at 9-months and 6-months post-BB-301 treatment, respectively, with...
DOYLESTOWN, Pa., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage biopharmaceutical company...
ADELAIDE, South Australia, Oct. 9, 2024 /PRNewswire/ -- BioCina Pty Ltd., a global end-to-end biologics Contract Development and Manufacturing Organization...
CAMBRIDGE, United Kingdom, Oct. 9, 2024 /PRNewswire/ -- Proteotype Diagnostics Ltd, in collaboration with the University of Southampton, has been awarded...
MELVILLE, N.Y., Oct. 9, 2024 /PRNewswire/ -- North American Partners in Anesthesia (NAPA) proudly announces the launch of its Patient...
DENVER, Oct. 09, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary...
SARASOTA, Fla., Oct. 09, 2024 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biopharmaceutical company committed to developing novel...
SAN FRANCISCO, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical stage biopharmaceutical company developing targeted...
KT-621 has demonstrated dupilumab-like activity and was well tolerated ina wide variety of preclinical models of TH2 diseases KT-621 is...